Insights

Innovative TherapeuticsOMEICOS Therapeutics offers innovative small molecule therapeutics for cardiovascular and ophthalmic diseases with enhanced biological activity compared to natural alternatives, presenting a unique selling proposition for targeted markets.

Recent FundingWith recent financing rounds, including a $19M Series C funding and a $2.72M grant, OMEICOS has solid financial backing to invest in sales strategies, expand market reach, and potentially explore new business opportunities.

Experienced LeadershipThe recruitment of top-tier executives like Chief Business Officer Simon Russell demonstrates OMEICOS' commitment to building a strong leadership team with expertise in driving business growth and sales expansion within the biopharmaceutical sector.

Strategic Board AppointmentsBy appointing independent Board Members such as Christian Schetter and bringing on experienced professionals like Holger Reithinger, OMEICOS strengthens its strategic decision-making capabilities, paving the way for targeted sales initiatives and partnerships.

Competitive PositioningWith a focus on metabolically robust synthetic analogues and phase 2a clinical studies for mitochondrial diseases, OMEICOS stands out among similar biotech companies, offering sales teams a differentiated product portfolio to position in competitive markets.

Similar companies to OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH Tech Stack

OMEICOS Therapeutics GmbH uses 8 technology products and services including WP-Statistics, Joomla, WordPress, and more. Explore OMEICOS Therapeutics GmbH's tech stack below.

  • WP-Statistics
    Analytics
  • Joomla
    Content Management System
  • WordPress
    Content Management System
  • Google Font API
    Font Scripts
  • Twitter Emoji (Twemoji)
    Font Scripts
  • MooTools
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Apache HTTP Server
    Web Servers

Media & News

OMEICOS Therapeutics GmbH's Email Address Formats

OMEICOS Therapeutics GmbH uses at least 1 format(s):
OMEICOS Therapeutics GmbH Email FormatsExamplePercentage
F.Last@omeicos.comJ.Doe@omeicos.com
50%
F.Last@omeicos.comJ.Doe@omeicos.com
50%

Frequently Asked Questions

Where is OMEICOS Therapeutics GmbH's headquarters located?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH's main headquarters is located at Robert-Roessle-Strasse 10 Berlin, 13125 DE. The company has employees across 1 continents, including Europe.

What is OMEICOS Therapeutics GmbH's phone number?

Minus sign iconPlus sign icon
You can contact OMEICOS Therapeutics GmbH's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OMEICOS Therapeutics GmbH's official website and social media links?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH's official website is omeicos.com and has social profiles on LinkedIn.

How much revenue does OMEICOS Therapeutics GmbH generate?

Minus sign iconPlus sign icon
As of December 2024, OMEICOS Therapeutics GmbH's annual revenue reached $1.8M.

What is OMEICOS Therapeutics GmbH's SIC code NAICS code?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OMEICOS Therapeutics GmbH have currently?

Minus sign iconPlus sign icon
As of December 2024, OMEICOS Therapeutics GmbH has approximately 9 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: R. F.Chief Business Officer: S. R.Vice President Operations & Ip: K. U.. Explore OMEICOS Therapeutics GmbH's employee directory with LeadIQ.

What industry does OMEICOS Therapeutics GmbH belong to?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH operates in the Biotechnology Research industry.

What technology does OMEICOS Therapeutics GmbH use?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH's tech stack includes WP-StatisticsJoomlaWordPressGoogle Font APITwitter Emoji (Twemoji)MooToolsjQueryApache HTTP Server.

What is OMEICOS Therapeutics GmbH's email format?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH's email format typically follows the pattern of . Find more OMEICOS Therapeutics GmbH email formats with LeadIQ.

How much funding has OMEICOS Therapeutics GmbH raised to date?

Minus sign iconPlus sign icon
As of December 2024, OMEICOS Therapeutics GmbH has raised $19M in funding. The last funding round occurred on Nov 02, 2018 for $19M.

When was OMEICOS Therapeutics GmbH founded?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH was founded in 2013.
OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH

Biotechnology ResearchBerlin, Germany2-10 Employees

OMEICOS Therapeutics has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat mitochondrial dysfunction, inflammatory, cardiovascular and other diseases. Epoxyeicosanoids activate cell type-specific endogenous pathways that promote organ and tissue protection. 
OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. The currently active PMD-OPTION Phase 2a clinical study is evaluating OMEICOS’ lead development program OMT-28 in patients with Primary Mitochondrial Disease.

Section iconCompany Overview

Headquarters
Robert-Roessle-Strasse 10 Berlin, 13125 DE
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $19M

    OMEICOS Therapeutics GmbH has raised a total of $19M of funding over 6 rounds. Their latest funding round was raised on Nov 02, 2018 in the amount of $19M.

  • $10M

    OMEICOS Therapeutics GmbH's revenue is in the range of $10M

Section iconFunding & Financials

  • $19M

    OMEICOS Therapeutics GmbH has raised a total of $19M of funding over 6 rounds. Their latest funding round was raised on Nov 02, 2018 in the amount of $19M.

  • $10M

    OMEICOS Therapeutics GmbH's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.